Clinical Report: U.S. Flu Cases Slightly Decline Amid Severe Season
Overview
Recent data indicate a minor decrease in U.S. flu cases and high activity states; however, the current flu season remains severe with rising hospitalizations and deaths. The predominant A H3N2 virus, especially the subclade K variant, differs from the vaccine strain, complicating prevention efforts.
Background
The U.S. is experiencing a severe influenza season, surpassing last winter's epidemic which was one of the harshest in recent history. The A H3N2 strain, known for causing significant morbidity and mortality in older adults, is the most frequently reported virus this season. Notably, a new subclade K variant of H3N2, not well matched by this year's vaccine, is prevalent. Flu-related hospitalizations and deaths, including pediatric fatalities, remain high despite slight declines in some flu activity indicators.
Data Highlights
Metric
Estimate/Count
Flu illnesses (season to date)
15 million
Hospitalizations
180,000
Deaths
7,400 (including 17 children)
States reporting high flu activity (last week)
44
Child flu deaths last season
289 (highest this century)
Key Findings
Flu cases and states with high flu activity showed a slight decline last week, but hospitalizations and deaths increased.
The predominant circulating virus is influenza A H3N2, with over 91% of infections caused by the subclade K variant, which differs from the vaccine strain.
This season has already resulted in at least 15 million illnesses, 180,000 hospitalizations, and 7,400 deaths, including 17 pediatric deaths.
Last season recorded the highest child flu deaths this century, totaling 289.
Federal health officials have recently ceased recommending universal flu vaccination for children, advising individualized decisions instead.
Other respiratory viruses like COVID-19 and RSV are also causing increased hospitalizations but remain less frequent than flu infections.
Clinical Implications
Clinicians should remain vigilant for severe influenza cases, especially given the predominance of a vaccine-mismatched H3N2 variant. Continued emphasis on early diagnosis and supportive care is critical. The recent change in pediatric flu vaccine recommendations necessitates careful shared decision-making with families to optimize protection for vulnerable children.
Conclusion
Despite a slight recent decline in flu activity, the U.S. is enduring a prolonged and severe influenza season driven by a predominant H3N2 variant poorly matched to vaccines. Ongoing surveillance and tailored clinical management remain essential to mitigate morbidity and mortality.
References
Associated Press/2024 -- Flu Cases in the U.S. Experience Minor Decrease, Yet Severe Season Continues